Novavax
NVAX
#5560
Rank
NZ$2.58 B
Marketcap
NZ$15.66
Share price
2.32%
Change (1 day)
23.59%
Change (1 year)

Earnings for Novavax (NVAX)

Earnings in 2026 (TTM): -NZ$0.13 Billion

According to Novavax's latest financial reports the company's current earnings are NZ$0.59 Billion. In 2025 the company made an earning of NZ$0.78 Billion, an increase over its 2024 earnings that were of -NZ$0.27 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Novavax from 1996 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$0.13 Billion-115.36%
2025 NZ$0.78 B-396.87%
2024 -NZ$0.27 Billion-70.39%
2023 -NZ$0.9 Billion-16.59%
2022 -NZ$1.08 Billion-62.58%
2021 -NZ$2.87 Billion320.54%
2020 -NZ$0.69 Billion234.22%
2019 -NZ$0.21 Billion-30.17%
2018 -NZ$0.3 Billion1.69%
2017 -NZ$0.29 Billion-36.44%
2016 -NZ$0.46 Billion70.4%
2015 -NZ$0.27 Billion89.27%
2014 -NZ$0.14 Billion59.83%
2013 -NZ$87.58 Million81.9%
2012 -NZ$48.15 Million50.33%
2011 -NZ$32.03 Million
2009 -NZ$63.21 Million8.8%
2008 -NZ$58.1 Million18.01%
2007 -NZ$49.23 Million18.33%
2006 -NZ$41.61 Million168.31%
2005 -NZ$15.51 Million-62.51%
2004 -NZ$41.37 Million52.4%
2003 -NZ$27.15 Million-28.21%
2002 -NZ$37.81 Million
2000 -NZ$21.55 Million177%
1999 -NZ$7.78 Million-11.54%
1998 -NZ$8.8 Million10.64%
1997 -NZ$7.95 Million-9.62%
1996 -NZ$8.8 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novartis
NVS
NZ$26.68 B-24,586.50%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$17.90 B-16,530.34%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$24.79 B-22,848.99%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
NZ$16.92 B-15,631.18%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
NZ$41.36 M-137.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-NZ$0.53 Billion 379.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
NZ$0.20 B-285.60%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
-NZ$13.68 Million-87.45%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-NZ$0.77 Billion 604.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
NZ$99.92 M-191.68%๐Ÿ‡บ๐Ÿ‡ธ USA